Cargando…

METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma

Detalles Bibliográficos
Autores principales: Li, Min, Xia, Mingyue, Zhang, Ziyu, Tan, Yanyin, Li, Enjie, Guo, Zhigang, Fang, Mingzhi, Zhu, Yong, Hu, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552725/
https://www.ncbi.nlm.nih.gov/pubmed/37503727
http://dx.doi.org/10.3892/ijo.2023.5549
_version_ 1785116019642073088
author Li, Min
Xia, Mingyue
Zhang, Ziyu
Tan, Yanyin
Li, Enjie
Guo, Zhigang
Fang, Mingzhi
Zhu, Yong
Hu, Zhigang
author_facet Li, Min
Xia, Mingyue
Zhang, Ziyu
Tan, Yanyin
Li, Enjie
Guo, Zhigang
Fang, Mingzhi
Zhu, Yong
Hu, Zhigang
author_sort Li, Min
collection PubMed
description
format Online
Article
Text
id pubmed-10552725
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-105527252023-10-06 METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma Li, Min Xia, Mingyue Zhang, Ziyu Tan, Yanyin Li, Enjie Guo, Zhigang Fang, Mingzhi Zhu, Yong Hu, Zhigang Int J Oncol Corrigendum D.A. Spandidos 2023-07-24 /pmc/articles/PMC10552725/ /pubmed/37503727 http://dx.doi.org/10.3892/ijo.2023.5549 Text en Copyright: © Li et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Corrigendum
Li, Min
Xia, Mingyue
Zhang, Ziyu
Tan, Yanyin
Li, Enjie
Guo, Zhigang
Fang, Mingzhi
Zhu, Yong
Hu, Zhigang
METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma
title METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma
title_full METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma
title_fullStr METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma
title_full_unstemmed METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma
title_short METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma
title_sort mettl3 antagonizes 5-fu chemotherapy and confers drug resistance in colorectal carcinoma
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552725/
https://www.ncbi.nlm.nih.gov/pubmed/37503727
http://dx.doi.org/10.3892/ijo.2023.5549
work_keys_str_mv AT limin mettl3antagonizes5fuchemotherapyandconfersdrugresistanceincolorectalcarcinoma
AT xiamingyue mettl3antagonizes5fuchemotherapyandconfersdrugresistanceincolorectalcarcinoma
AT zhangziyu mettl3antagonizes5fuchemotherapyandconfersdrugresistanceincolorectalcarcinoma
AT tanyanyin mettl3antagonizes5fuchemotherapyandconfersdrugresistanceincolorectalcarcinoma
AT lienjie mettl3antagonizes5fuchemotherapyandconfersdrugresistanceincolorectalcarcinoma
AT guozhigang mettl3antagonizes5fuchemotherapyandconfersdrugresistanceincolorectalcarcinoma
AT fangmingzhi mettl3antagonizes5fuchemotherapyandconfersdrugresistanceincolorectalcarcinoma
AT zhuyong mettl3antagonizes5fuchemotherapyandconfersdrugresistanceincolorectalcarcinoma
AT huzhigang mettl3antagonizes5fuchemotherapyandconfersdrugresistanceincolorectalcarcinoma